Skip to main content
Erschienen in: International Journal of Legal Medicine 5/2009

01.09.2009 | Original Article

Fatal and severe codeine intoxication in 3-year-old twins—interpretation of drug and metabolite concentrations

verfasst von: Nerea Ferreirós, Sebastian Dresen, Maren Hermanns-Clausen, Volker Auwaerter, Annette Thierauf, Christoph Müller, Roland Hentschel, Rainer Trittler, Gisela Skopp, Wolfgang Weinmann

Erschienen in: International Journal of Legal Medicine | Ausgabe 5/2009

Einloggen, um Zugang zu erhalten

Abstract

This work presents two cases of codeine intoxication in 3-year-old monozygotic twin brothers while treated with a codeine slow-release formulation. One child had to be admitted to the hospital, whereas the other one died at home after aspiration of gastric content. The concentrations of codeine and major metabolites including morphine and corresponding glucuronide conjugates were measured by liquid chromatography–tandem mass spectrometry in serum, urine, cerebrospinal fluid, and brain tissue, respectively. A genetic polymorphism study was carried out in order to determine the ability of the children to metabolize codeine by O-demethylation. A pharmacokinetic calculation was also performed to estimate the administered dose of codeine in question. High concentrations of all substances were found in samples of both children. The pharmacokinetic estimate suggests an overdose of codeine, and the possible reasons for the high opiate concentrations are discussed. Furthermore, the postmortem distribution—during and after resuscitation—might play a major role in the interpretation of postmortem concentration levels.
Literatur
1.
Zurück zum Zitat Ellenhorn MJ, Barceloux DG (1988) Medical toxicology, diagnosis and treatment of human poisoning. Elsevier, New York, pp 698–709 Ellenhorn MJ, Barceloux DG (1988) Medical toxicology, diagnosis and treatment of human poisoning. Elsevier, New York, pp 698–709
2.
Zurück zum Zitat Williams DG, Hatch DJ, Howard RF (2001) Codeine phosphate in paediatric medicine. Br J Anaesth 86:413–421PubMedCrossRef Williams DG, Hatch DJ, Howard RF (2001) Codeine phosphate in paediatric medicine. Br J Anaesth 86:413–421PubMedCrossRef
3.
Zurück zum Zitat American Academy of Pediatrics, Committee on Drugs (1997) Use of codeine- and dextromethorphan-containing cough remedies in children. Pediatrics 99:918–920CrossRef American Academy of Pediatrics, Committee on Drugs (1997) Use of codeine- and dextromethorphan-containing cough remedies in children. Pediatrics 99:918–920CrossRef
4.
Zurück zum Zitat Schaeffeler E, Schwab M, Eichelbaum M, Zanger UM (2003) CYP2D6 genotyping strategy based on gene copy number determination by TaqMan real-time PCR. Hum Mutat 22:476–485PubMedCrossRef Schaeffeler E, Schwab M, Eichelbaum M, Zanger UM (2003) CYP2D6 genotyping strategy based on gene copy number determination by TaqMan real-time PCR. Hum Mutat 22:476–485PubMedCrossRef
5.
Zurück zum Zitat Toennes SW, Maurer HH (1997) Microsoft Excel in pharmacokinetics—an easy way to solve kinetic problems in clinical toxicology, legal medicine or doping control. In: Sachs H, Bernhard W, Jeger A (eds) Proceedings to 34th International TIAFT Meeting, Interlaken, 11–15 August 1996. Molina, Leipzig, pp 201–204 Toennes SW, Maurer HH (1997) Microsoft Excel in pharmacokinetics—an easy way to solve kinetic problems in clinical toxicology, legal medicine or doping control. In: Sachs H, Bernhard W, Jeger A (eds) Proceedings to 34th International TIAFT Meeting, Interlaken, 11–15 August 1996. Molina, Leipzig, pp 201–204
6.
Zurück zum Zitat Williams DG, Patel A, Howard RF (2002) Pharmacogenetics of codeine metabolism in an urban population of children and its implications for analgesic reliability. Br J Anaesth 89:839–845PubMedCrossRef Williams DG, Patel A, Howard RF (2002) Pharmacogenetics of codeine metabolism in an urban population of children and its implications for analgesic reliability. Br J Anaesth 89:839–845PubMedCrossRef
8.
Zurück zum Zitat Kintz P, Tracqui A, Mangin P (1991) Codeine concentrations in human samples in a case of fatal ingestion. Int J Legal Med 104:177–178PubMedCrossRef Kintz P, Tracqui A, Mangin P (1991) Codeine concentrations in human samples in a case of fatal ingestion. Int J Legal Med 104:177–178PubMedCrossRef
9.
Zurück zum Zitat Kirchheiner J, Schmidt H, Tzvetkov M, Keulen JT, Lötsch J, Roots I, Bröckmöller J (2007) Pharmacokinetics of codeine and its metabolite morphine in ultra-rapid metabolizers due to CYP2D6 duplication. Pharmacogenomics J 7:257–265PubMedCrossRef Kirchheiner J, Schmidt H, Tzvetkov M, Keulen JT, Lötsch J, Roots I, Bröckmöller J (2007) Pharmacokinetics of codeine and its metabolite morphine in ultra-rapid metabolizers due to CYP2D6 duplication. Pharmacogenomics J 7:257–265PubMedCrossRef
10.
Zurück zum Zitat Madlon-Kay DJ, Mosch FS (2000) Liquid medication dosing errors. J Fam Pract 49:741–744PubMed Madlon-Kay DJ, Mosch FS (2000) Liquid medication dosing errors. J Fam Pract 49:741–744PubMed
11.
Zurück zum Zitat Teske J, Weller JP, Larsch K, Tröger HD, Karst M (2007) Fatal outcome in a child after ingestion of a transdermal fentanyl patch. Int J Legal Med 121:147–151PubMedCrossRef Teske J, Weller JP, Larsch K, Tröger HD, Karst M (2007) Fatal outcome in a child after ingestion of a transdermal fentanyl patch. Int J Legal Med 121:147–151PubMedCrossRef
12.
Zurück zum Zitat Bronstein AC, Spyker DA, Cantilena LR, Green J, Rumack BH, Heard SE (2007) 2006 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS). Clin Toxicol 45:815–917CrossRef Bronstein AC, Spyker DA, Cantilena LR, Green J, Rumack BH, Heard SE (2007) 2006 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS). Clin Toxicol 45:815–917CrossRef
13.
Zurück zum Zitat Loetsch J (2005) Pharmacokinetic–pharmacodynamic modeling of opioids. J Pain Symptom Manage 29:90–103CrossRef Loetsch J (2005) Pharmacokinetic–pharmacodynamic modeling of opioids. J Pain Symptom Manage 29:90–103CrossRef
14.
Zurück zum Zitat Chen ZR, Somogyi AA, Bochner F (1988) Polymorphic O-demethylation of codeine. Lancet 2:914–915PubMedCrossRef Chen ZR, Somogyi AA, Bochner F (1988) Polymorphic O-demethylation of codeine. Lancet 2:914–915PubMedCrossRef
15.
Zurück zum Zitat Marez D, Legrand M, Sabbagh N et al (1997) Polymorphism of the cytochrome P450 CYP2D6 gene in a European population: characterization of 48 mutations and 53 alleles, their frequencies and evolution. Pharmacogenetics 7:193–202PubMedCrossRef Marez D, Legrand M, Sabbagh N et al (1997) Polymorphism of the cytochrome P450 CYP2D6 gene in a European population: characterization of 48 mutations and 53 alleles, their frequencies and evolution. Pharmacogenetics 7:193–202PubMedCrossRef
16.
Zurück zum Zitat Coffman BL, Rios GR, King CD, Tephly TR (1997) Human UGT2B7 catalyzes morphine glucuronidation. Drug Metab Dispos 25:1–4PubMed Coffman BL, Rios GR, King CD, Tephly TR (1997) Human UGT2B7 catalyzes morphine glucuronidation. Drug Metab Dispos 25:1–4PubMed
17.
Zurück zum Zitat Green MD, King CD, Mojarrabi B, Mackenzie PI, Tephly TR (1998) Glucuronidation of amines and other xenobiotics catalyzed by expressed human UDP-glucuronosyltransferase 1A3. Drug Metab Dispos 26:507–512PubMed Green MD, King CD, Mojarrabi B, Mackenzie PI, Tephly TR (1998) Glucuronidation of amines and other xenobiotics catalyzed by expressed human UDP-glucuronosyltransferase 1A3. Drug Metab Dispos 26:507–512PubMed
18.
Zurück zum Zitat Donnelly S, Davis MP, Walsh D, Naughton M (2002) Morphine in cancer pain management: a practical guide. Support Care Cancer 10:13–35PubMedCrossRef Donnelly S, Davis MP, Walsh D, Naughton M (2002) Morphine in cancer pain management: a practical guide. Support Care Cancer 10:13–35PubMedCrossRef
19.
Zurück zum Zitat Armstrong SC, Cozza KL (2003) Pharmacokinetic drug interactions of morphine, codeine, and their derivatives: theory and clinical reality, part I. Psychosomatics 44:167–171PubMedCrossRef Armstrong SC, Cozza KL (2003) Pharmacokinetic drug interactions of morphine, codeine, and their derivatives: theory and clinical reality, part I. Psychosomatics 44:167–171PubMedCrossRef
20.
Zurück zum Zitat Penson RT, Joel JP, Bakhshi K, Clark SJ, Langford RM, Slevin ML (2000) Randomized placebo-controlled trial of the activity of the morphine glucuronides. Clin Pharmacol Ther 68:667–676PubMedCrossRef Penson RT, Joel JP, Bakhshi K, Clark SJ, Langford RM, Slevin ML (2000) Randomized placebo-controlled trial of the activity of the morphine glucuronides. Clin Pharmacol Ther 68:667–676PubMedCrossRef
21.
Zurück zum Zitat Loetsch J, Geisslinger G (2001) Morphine-6-glucuronide: an analgesic of the future? Clin Pharmacokinet 40:485–499CrossRef Loetsch J, Geisslinger G (2001) Morphine-6-glucuronide: an analgesic of the future? Clin Pharmacokinet 40:485–499CrossRef
22.
Zurück zum Zitat Wahlstrom A, Lenhammar L, Ask B, Rane A (1994) Tricyclic antidepressants inhibit opioid receptor binding in human brain and hepatic morphine glucuronidation. Pharmacol Toxicol 75:23–27PubMedCrossRef Wahlstrom A, Lenhammar L, Ask B, Rane A (1994) Tricyclic antidepressants inhibit opioid receptor binding in human brain and hepatic morphine glucuronidation. Pharmacol Toxicol 75:23–27PubMedCrossRef
23.
Zurück zum Zitat Takeda S, Ishii Y, Iwanaga M et al (2005) Modulation of UDP-glucuronosyltransferase function by cytochrome P450: evidence for the alteration of UGT2B7-catalyzed glucuronidation of morphine by CYP3A4. Mol Pharmacol 67:665–672PubMedCrossRef Takeda S, Ishii Y, Iwanaga M et al (2005) Modulation of UDP-glucuronosyltransferase function by cytochrome P450: evidence for the alteration of UGT2B7-catalyzed glucuronidation of morphine by CYP3A4. Mol Pharmacol 67:665–672PubMedCrossRef
24.
25.
Zurück zum Zitat Skopp G, Lutz R, Gansmann B, Mattern R, Aderjan R (1996) Postmortem distribution pattern of morphine and morphine glucuronides in heroin overdose. Int J Legal Med 109:118–124PubMedCrossRef Skopp G, Lutz R, Gansmann B, Mattern R, Aderjan R (1996) Postmortem distribution pattern of morphine and morphine glucuronides in heroin overdose. Int J Legal Med 109:118–124PubMedCrossRef
26.
Zurück zum Zitat Wildfeuer A, Pfaff G, Lach P (1994) Biopharmazeutische Eigenschaften von retardiertem Codeinphosphat. Arzneim-Forsch/Drug Res 44:758–761 Wildfeuer A, Pfaff G, Lach P (1994) Biopharmazeutische Eigenschaften von retardiertem Codeinphosphat. Arzneim-Forsch/Drug Res 44:758–761
27.
Zurück zum Zitat Aderjan RE, Skopp G (1998) Formation and clearance of active and inactive metabolites of opiates in humans. Ther Drug Monit 20:561–569PubMedCrossRef Aderjan RE, Skopp G (1998) Formation and clearance of active and inactive metabolites of opiates in humans. Ther Drug Monit 20:561–569PubMedCrossRef
Metadaten
Titel
Fatal and severe codeine intoxication in 3-year-old twins—interpretation of drug and metabolite concentrations
verfasst von
Nerea Ferreirós
Sebastian Dresen
Maren Hermanns-Clausen
Volker Auwaerter
Annette Thierauf
Christoph Müller
Roland Hentschel
Rainer Trittler
Gisela Skopp
Wolfgang Weinmann
Publikationsdatum
01.09.2009
Verlag
Springer-Verlag
Erschienen in
International Journal of Legal Medicine / Ausgabe 5/2009
Print ISSN: 0937-9827
Elektronische ISSN: 1437-1596
DOI
https://doi.org/10.1007/s00414-009-0340-0

Weitere Artikel der Ausgabe 5/2009

International Journal of Legal Medicine 5/2009 Zur Ausgabe

Editorial

Editorial

Neu im Fachgebiet Rechtsmedizin